Search results
Results from the WOW.Com Content Network
Bitot's spots are the buildup of keratin located superficially in the conjunctiva of human's eyes. They can be oval, triangular or irregular in shape. The spots are a sign of vitamin A deficiency and associated with drying of the cornea. In 1863, the French physician Pierre Bitot (1822–1888) first described these spots. [1]
The condition is not congenital and develops over the course of a few months as the lacrimal glands fail to produce tears. Other conditions involved in the progression already stated include the appearance of Bitot's spots, which are clumps of keratin debris that build up inside the conjunctiva and night blindness, which precedes corneal ulceration and total blindness.
Bitot's spots Pierre Alain Bitôt (22 March 1822, in Podensac – 2 February 1888) was a French physician , anatomist and surgeon ; remembered for describing Bitot's spots . Biography
Typical location of Bitot's spots. Xerophthalmia, caused by a severe vitamin A deficiency, is described by pathologic dryness of the conjunctival epithelium and cornea. The conjunctiva becomes dry, thick, and wrinkled. Indicative is the appearance of Bitot's spots, which are clumps of keratin debris that build up inside the conjunctiva.
If your whole eye has gone red, learn about the causes of bloodshot eyes and how to fix them. Weirdly enough, a red spot on eye might have a cause totally unrelated to your eyes: sneezing or coughing.
Night blindness and its worsened condition, xerophthalmia, are markers of Vitamin A deficiency; collections of keratin in the conjunctiva, known as Bitot's spots, and ulceration and necrosis of cornea keratomalacia can be seen. Conjunctival epithelial defects occur around lateral aspect of the limbus in the subclinical stage of VAD.
NBC Select editors tested the best acne spot treatments, including gels, pimple patches, and creams from brands like La Roche-Posay, Zitsticka, Differin and more.
Ulcerative vernal keratitis require surgical treatment in the form of debridement, superficial keratectomy, excimer laser therapeutic keratectomy, as well as amniotic membrane transplantation to enhance re-epithelialisation. Recently treatment with tacrolimus ointment (0.1%) used topically twice daily is showing encouraging results.